Medipines is a medical equipment maker which is based in Orange County, California, United States.[1] Steve Lee is the incumbent chief executive officer of the company.[2]
MediPines is known for its device, AGM100, which is approved for respiratory diagnosis and identifying the symptoms of COVID-19 using parameters such as oxygen saturation levels.[3] The device is being used in the United States.[4]
MediPines was incorporated in 2013.[5] They are known for their device, AGM100, which provides non-invasive pulmonary gas exchange measurements in a short period of time.[2] Approved by FDA, the device was developed in California and has been tested at the University of British Columbia.[6][7] It is in use in Canadian hospitals.[7]
In July 2020, it received the National Consortium for Pediatric Device award for developing a monitor device that displays a critical analysis of patients' breathing samples.[8] In the same year, MDTech included MediPines in their annual list.[9]
In August 2021, the AGM100 was included in the WHO Compendium.[10]
This article needs additional or more specific categories. (September 2022) |
![]() | Original source: https://en.wikipedia.org/wiki/Medipines.
Read more |